PPT-Jaimee Doucette T helper cells in IBD

Jaimee Doucette T helper cells in IBD Overview Background Information on T Helper cells What is known about Th cells in IBD What is still unknown about Th cells in IBD Paper 1 Paper 2 Future studiesspecific aims. Judy H. Cho, M.D. . Ward-Coleman Professor of Translational . Genetics and . Medicine, Icahn School of Medicine at Mount Sinai. December 6th, 2014. Questions . What naturally occurring genetic polymorphisms are associated with IBD? . AGM March 2012 . IBD PURPOSE STATEMENT. ". To be . recognised. as the world's leading members . organisation. for the advancement of education and training  in the science and technology of brewing, distilling and related industries.". Eva Szigethy MD, PhD . Associate Professor of Psychiatry, Pediatrics and Medicine. Director, Visceral Inflammation and Pain (VIP) Center. Division of Gastroenterology. szigethye@upmc.edu. Szigethy: Disclosures. Dr. Hannah Gordon, Prof Timothy Orchard, . Dr. Alan Steel, . Dr. Marcus . Harbord. ECCO 2015 Barcelona. Declarations:. The authors have no competing interests. Funded by an unrestricted grant from the Jesse and Thomas Tam Family Foundation. Dr Hannah Gordon. Clinical Research Fellow. Chelsea and Westminster Hospital. Introduction. Review . History of twin studies. Twin studies in IBD. New molecular techniques in IBD. UK IBD Nixon Twin and Multiplex Registry. Richard Driscoll. Chairman. IBD Standards Group. 2006 – 2012: IBD UK-wide projects. 2006 IBD Audit (1). 2007 IBD Standards Group formed. 2008 IBD Audit (2) into the Annual Health Check. 2009 IBD Standards launched with political lobbying. 1000 . Genomes Project Phase 3 data reveals relationships from Neandertals to present day families. Gundula Povysil. Johannes . Kepler University . Linz. Austria. Identity . by Descent (IBD). Gundula Povysil. Counselling . Department. Faculty of Cognitive Sciences . & Human . Development. Universiti Malaysia Sarawak. Fatahyah Yahya. KMC 1083: Basic Helping . Skills. What is HELPING?. What is HELPER?. What is HELPEEE?. This program will include a discussion of . investigational agents not approved by the FDA for use in the United States. . IBD Background. Evolving Treatment Landscape in IBD. Limitations of Current IBD Therapies. Jim . Gelder. , CEO, HCB. Trey Wall, VP, IBD Strategies, HCB. Garry Shelton, Director, National Sales Desk, HCB. Shift In Life Insurance Distribution. Independent . professional life agents . brokers . Management of IBD. Sprint or Marathon?. Challenges and Unmet Needs. The Sprint. When Sprinting Matters. After the Sprint. What Happens Next?. The Marathon. Long-Term Remission. Why Is It Important?. Colectomy Rates in Patients With UC Are Decreasing . Keys to Successful Diagnosis, Treatment, and Ongoing Care. Lisa Malter, MD. Professor. Department of Medicine. Division of Gastroenterology. NYU Grossman School of Medicine. New York, New York. Dermot McGovern, MD, PhD, FRCP, FACG. Lecture 1 and 2. Gene Therapy. Definition: . the . introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders. .. Approaches: . Replacing a mutated gene that causes disease with a healthy copy of the gene.. Sara Horst MD MPH. Alan Moss MD . Extra-intestinal Manifestations. Prevalence and incidence depends on definition: 6-47%. Can appear before or after diagnosis. Rogler. G et al. Gastroenterology 2021.